OTCMKTS:VVCIFVIVO Cannabis Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding VIVO Cannabis Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.19 +0.01 (+5.56 %) (As of 07/31/2020 04:00 PM ET) Add Compare Share Today's Range$0.18Now: $0.19▼$0.1950-Day Range$0.16MA: $0.17▼$0.1952-Week Range$0.11Now: $0.19▼$0.43Volume302,490 shsAverage Volume169,679 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsHeadlinesSocial Media VIVO Cannabis Inc. manufactures and distributes medical cannabis. The company was formerly known as ABcann Global Corporation and changed its name to VIVO Cannabis Inc. in August 2018. The company is headquartered in Napanee, Canada.Read More Beat the Market (BTM) Rank™ 3.3 Analyst's Opinion Consensus RatingVIVO Cannabis has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $0.70, VIVO Cannabis has a potential upside of 269.0% from its current price of $0.19.Amount of Analyst CoverageVIVO Cannabis has only been the subject of 1 research reports in the past 90 days. Previous Next 3.3 Community Rank Outperform VotesVIVO Cannabis has received 38 “outperform” votes. (Add your “outperform” vote.)Underperform VotesVIVO Cannabis has received 20 “underperform” votes. (Add your “underperform” vote.)Community SentimentVIVO Cannabis has received 65.52% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about VIVO Cannabis and other stocks. Vote “Outperform” if you believe VVCIF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe VVCIF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldVIVO Cannabis does not currently pay a dividend.Dividend GrowthVIVO Cannabis does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, VIVO Cannabis insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.3Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.31 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:VVCIF Previous Symbol CUSIPN/A CIKN/A Webvivocannabis.com Phone855-322-2266Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable $0.19 +0.01 (+5.56 %) (As of 07/31/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive VVCIF News and Ratings via Email Sign-up to receive the latest news and ratings for VVCIF and its competitors with MarketBeat's FREE daily newsletter. VIVO Cannabis (OTCMKTS:VVCIF) Frequently Asked Questions How has VIVO Cannabis' stock been impacted by COVID-19 (Coronavirus)? VIVO Cannabis' stock was trading at $0.1620 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, VVCIF stock has increased by 17.1% and is now trading at $0.1897. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of VIVO Cannabis? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for VIVO Cannabis in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for VIVO Cannabis. What price target have analysts set for VVCIF? 2 equities research analysts have issued 12-month price targets for VIVO Cannabis' stock. Their forecasts range from $0.70 to $0.70. On average, they expect VIVO Cannabis' share price to reach $0.70 in the next year. This suggests a possible upside of 269.0% from the stock's current price. View analysts' price targets for VIVO Cannabis. Has VIVO Cannabis been receiving favorable news coverage? News headlines about VVCIF stock have trended negative recently, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. VIVO Cannabis earned a media sentiment score of -2.9 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the near future. View the latest news about VIVO Cannabis. Who are some of VIVO Cannabis' key competitors? Some companies that are related to VIVO Cannabis include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF), Cipher Pharmaceuticals (CPHRF) and CLS Holdings USA (CLSH). View all competitors. Who are VIVO Cannabis' key executives? VIVO Cannabis' management team includes the following people: Mr. Barry Fishman, CEO & Director (Age 62)Dr. Michael Scott Bumby, Chief Financial Officer (Age 55)Mr. Andrew LaCroix, VP of International Bus. & Gen. Counsel (Age 49)Ms. Ying Guan, VP of Napanee Operations & Sec. (Age 37)Mr. Daniel Laflamme, COO & Director What is VIVO Cannabis' stock symbol? VIVO Cannabis trades on the OTCMKTS under the ticker symbol "VVCIF." How do I buy shares of VIVO Cannabis? Shares of VVCIF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is VIVO Cannabis' stock price today? One share of VVCIF stock can currently be purchased for approximately $0.19. What is VIVO Cannabis' official website? The official website for VIVO Cannabis is vivocannabis.com. How can I contact VIVO Cannabis? The company can be reached via phone at 855-322-2266. This page was last updated on 8/3/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
